Quantinuum

Quantinuum

Signal active

Organization

Contact Information

Overview

Quantinuum is a quantum company dedicated to the advancement of quantum computers and the development of software solutions. Quantinuum's technology spearheads advancements in materials discovery, cybersecurity, and next-generation quantum AI. The company has nearly 500 professionals, including over 370 scientists and engineers, Quantinuum takes the helm in driving the quantum computing revolution globally.

About

Industries

Cyber Security, Software Engineering, Quantum Computing

Founded

2021

Employees

251-500

Headquarters locations

Broomfield, Colorado, United States, North America

Social

Profile Resume

Quantinuum headquartered in United States, North America, operates in the Cyber Security, Software Engineering, Quantum Computing sector. The company focuses on Cyber Security and has secured $7.8B in funding across 24 round(s). With a team of 251-500 employees, Quantinuum is actively contributing to advancements in Cyber Security. Their latest funding round, Corporate Round - Quantinuum, raised $300.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Rajeeb Hazra

Rajeeb Hazra

President & Chief Executive Officer

imagePlace Susan Schwamberger

Susan Schwamberger

Chief Human Resources Officer & VP Operations

imagePlace Jeff Miller

Jeff Miller

CIO

imagePlace Denise Holmquist

Denise Holmquist

CFO

imagePlace Kaniah Konkoly-Thege

Kaniah Konkoly-Thege

Chief Legal Officer

Funding Rounds

Funding rounds

2

Investors

4

Lead Investors

0

Total Funding Amount

$325.0M

Details

0

Quantinuum has raised a total of $325.0M in funding over 0 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor

Investors

Quantinuum is funded by 11 investors.

Investor NameLead InvestorFunding RoundPartners
Quantinuum-FUNDING ROUND - Quantinuum300.0M
JP Morgan Chase-FUNDING ROUND - JP Morgan Chase300.0M
Quantinuum-FUNDING ROUND - Quantinuum300.0M
Amgen-FUNDING ROUND - Amgen300.0M